-
-
-
Biogen's 2024 Financial Report
Financial statements
Biogen cuts four pipeline programs and secures a $1.8 billion deal with Royalty Pharma. Leqembi, its Alzheimer’s treatment, achieves $281M in global sales for 2024. Multiple sclerosis remains its top revenue driver amid a 2% overall revenue decline.
开阳县|
莒南县|
拜泉县|
上栗县|
高密市|
营口市|
北京市|
塔城市|
北京市|
正宁县|
彭州市|
保康县|
朔州市|
沙田区|
古蔺县|
古田县|
敦化市|
山西省|
云林县|
永德县|
遂平县|
东光县|
改则县|
灵川县|
定兴县|
大理市|
逊克县|
韩城市|
龙海市|
西昌市|
丰镇市|
老河口市|
昭觉县|
平遥县|
崇左市|
武川县|
东兴市|
苏州市|
贡嘎县|
南汇区|
新晃|